FULL SUPPLEMENT: Targeting Acne Pathogenesis with Topical Therapies

October 2024 | Volume 23 | Issue 10 | 54120s1 | Copyright © October 2024


Published online September 27, 2024

Emmy M. Graber MD MBA

The Dermatology Institute of Boston, Boston, MA
Affiliate Clinical Instructor, Northeastern University, Boston, MA

Abstract
We, as dermatologists, are exceedingly lucky.  We can watch our patients improve before our eyes. In clinical practice, we don't often track a quantitative metric to gauge success but rather measure the success of our treatment by the appearance of our patients' skin.
In this supplement

Topical Acne Therapies and Their Pathogenic Targets 

We, as dermatologists, are exceedingly lucky.  We can watch our patients improve before our eyes.  In clinical practice, we don't often track a quantitative metric to gauge success but rather measure the success of our treatment by the appearance of our patients' skin. 

Read the article here.


Pathophysiologic Targets of Acne Treatment 

Acne vulgaris is an extremely common dermatologic condition. Individuals with acne present not only to dermatologists, but also to internists, family medicine physicians, pediatricians, estheticians, and beauty counters alike in search of a treatment.  

Read the article here.
Watch the video abstract for this article here: